Neighborhood Disadvantage is Not Associated with Exposure to NMOSD Treatment (P11-8.009)
To assess whether neighborhood-level disadvantage is associated with time to initiation of an immunosuppressive therapy (IST) among persons with neuromyelitis optica spectrum disorder (pwNMOSD).
Authors
- Amy Kunchok (ORCID: https://orcid.org/0000-0002-8387-6491)
- Albert Aboseif (ORCID: https://orcid.org/0000-0001-5053-8544)
- Kaitlyn Palmer
- Julia O’Mahony (ORCID: https://orcid.org/0000-0001-8338-1133)
- Deborah Miller (ORCID: https://orcid.org/0000-0002-8026-1854)
- Justin Abbatemarco (ORCID: https://orcid.org/0000-0003-1668-4753)
- Julie Widmar
- Devon Conway (ORCID: https://orcid.org/0000-0001-5359-6686)
- Mengke Du
- Carol Swetlik
Institutions
- MetroHealth (US)
- Cleveland Clinic (US)
- Mayo Clinic (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210520
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00